CeriBell Inc
NASDAQ:CBLL
Net Margin
CeriBell Inc
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | Company | Market Cap |
Net Margin |
||
---|---|---|---|---|---|
US |
C
|
CeriBell Inc
NASDAQ:CBLL
|
543.1m USD |
-62%
|
|
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
220.2B USD |
32%
|
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
177.7B USD |
29%
|
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
157B USD |
12%
|
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
154.2B USD |
12%
|
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
119.1B USD |
14%
|
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
53.8B EUR |
9%
|
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
53.1B USD |
7%
|
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
46.9B USD |
73%
|
|
US |
![]() |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.6B USD |
23%
|
|
US |
![]() |
Resmed Inc
NYSE:RMD
|
40.4B USD |
26%
|
CeriBell Inc
Glance View
Ceribell, Inc. is a commercial-stage medical technology company, which focuses on transforming the diagnosis and management of patients with serious neurological conditions. The company is headquartered in Sunnyvale, California and currently employs 281 full-time employees. The company went IPO on 2024-10-11. The company is focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Point-of-Care EEG enables early detection and management of suspected seizure patients, promoting precise patient care and hospital-wide efficiencies. Its Clarity AI algorithm interprets EEG in real-time, provides bedside alerts and continuous monitoring for status epilepticus. The Ceribell EEG Portal makes it easy to remotely review EEG in real-time with pre-annotated EEG insights.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on CeriBell Inc's most recent financial statements, the company has Net Margin of -61.8%.